patient

How to create an integrated social media and digital strategy for patients

October 11, 2017

Social Media in Pharma

How to create an integrated social media and digital strategy for patients

https://pharmaphorum.com/partner-content/how-to-create-an-integrated-social-media-and-digital-strategy-for-patients/

Eye on ESMO 2016

October 8, 2016

The largest dedicated oncology conference in Europe, ESMO 2016, takes place 7-11 October.pharmaphorum was onsite and in conjunction

Eye on ESMO 2016

https://pharmaphorum.com/views-and-analysis/eye-on-esmo-2016/

World Alzheimer’s Day: latest research and a carer’s perspective

September 21, 2016

On World Alzheimer’s Day, pharmaphorum looks at statistics, current research and the impact of dementia on families.

World Alzheimer’s Day: latest research and a carer’s perspective

https://pharmaphorum.com/views-and-analysis/world-alzheimers-day-latest-research-patients-perspective/

Available on-demand: COPD, connecting real world needs to patient centric solutions

January 19, 2015

COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and

Available on-demand: COPD, connecting real world needs to patient centric solutions

https://pharmaphorum.com/webinars/live-webinar-debate-feb-4th-copd-connecting-real-world-needs-to-patient-centric-solutions-price-is-right-uk-niche-market-access-2/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

patient

Eye on ESMO 2016

World Alzheimer’s Day: latest research and a carer’s perspective

Available on-demand: COPD, connecting real world needs to patient centric solutions

SMi's 12th annual Cold Chain Distribution Conference and Exhibition

RNA Therapeutics 2018

Ophthalmic Drugs - Europe's Leading Ophthalmic Conference

CRISPR & Precision Gene Editing Congress - Berlin 2017

ICI Summit Europe 2017

Neoantigen Summit 2017

FDA approval gained, Glaxo awaits key committee blessing for Shingrix

NICE rejects Bayer and Eisai drugs in thyroid cancer

After surging on lung cancer data, Ignyta looks to raise $160m

Celgene axes gene silencing drug in Crohn’s

uniQure presses ‘refresh’ on haemophilia gene therapy, gets FDA blessing

Nanomedicine: delivering on its promise?

The Patient Summit Europe – Day 1 coverage

Immigration is the Brexit bogeyman, and it’s hurting pharma already

Navigating the barriers to successful market access

Rare disease market research needs a multifaceted approach

Search

Advanced Search

Trending

patient